| Year |
Citation |
Score |
| 2022 |
Zou J, Li L, Zheng P, Liang W, Hu S, Zhou S, Wang Y, Zhao J, Yuan D, Liu L, Wu D, Xu M, Zhang F, Zhu M, Wu Z, ... ... Gao C, et al. Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance. The Journal of Clinical Investigation. 132. PMID 35108220 DOI: 10.1172/JCI154987 |
0.323 |
|
| 2021 |
Dimasi N, Kumar A, Gao C. Generation of bispecific antibodies using chemical conjugation methods. Drug Discovery Today. Technologies. 40: 13-24. PMID 34916015 DOI: 10.1016/j.ddtec.2021.08.006 |
0.371 |
|
| 2020 |
Kumar A, Mao S, Dimasi N, Gao C. Design and Validation of Linkers for Site-Specific Preparation of Antibody-Drug Conjugates Carrying Multiple Drug Copies Per Cysteine Conjugation Site. International Journal of Molecular Sciences. 21. PMID 32961794 DOI: 10.3390/Ijms21186882 |
0.459 |
|
| 2019 |
Steinhardt J, Wu Y, Fleming R, Ruddle BT, Patel P, Wu H, Gao C, Dimasi N. Fab-Arm Exchange Combined with Selective Protein A Purification Results in a Platform for Rapid Preparation of Monovalent Bispecific Antibodies Directly from Culture Media. Pharmaceutics. 12. PMID 31861347 DOI: 10.3390/pharmaceutics12010003 |
0.322 |
|
| 2019 |
St Amant AH, Huang F, Lin J, Lemen D, Chakiath C, Mao S, Fazenbaker C, Zhong H, Harper J, Xu W, Patel NV, Adams LR, Vijayakrishnan B, Howard PW, Marelli M, ... ... Gao C, et al. A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates Through a Diels-Alder Reaction with Maleimide. Bioconjugate Chemistry. PMID 31380623 DOI: 10.1021/Acs.Bioconjchem.9B00436 |
0.373 |
|
| 2019 |
Li JY, Perry SR, Muniz-Medina V, Wang X, Wetzel LK, Rebelatto MC, Masson Hinrichs MJ, Bezabeh BZ, Fleming RL, Dimasi N, Feng H, Toader D, Yuan AQ, Xu L, Lin J, ... Gao C, et al. A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. Cancer Cell. 35: 948-949. PMID 31185215 DOI: 10.1016/j.ccell.2019.05.010 |
0.302 |
|
| 2019 |
St Amant AH, Huang F, Lin J, Rickert K, Oganesyan V, Lemen D, Mao S, Harper J, Marelli M, Wu H, Gao C, Read de Alaniz J, Christie RJ. A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels-Alder Reaction with Maleimide or Proximity-Based Dimerization. Angewandte Chemie (International Ed. in English). PMID 31018033 DOI: 10.1002/Anie.201903494 |
0.352 |
|
| 2019 |
Ruddle BT, Fleming R, Wu H, Gao C, Dimasi N. Characterization of disulfide bond rebridged Fab-drug conjugates prepared using a dual maleimide pyrrolobenzodiazepine cytotoxic payload. Chemmedchem. PMID 30980702 DOI: 10.1002/cmdc.201900077 |
0.462 |
|
| 2019 |
Li Q, Barrett A, Vijayakrishnan B, Tiberghien AC, Beard R, Rickert K, Allen K, Christie RJ, Marelli M, Harper J, Howard PW, Wu H, Dall'Acqua WF, Tsui P, Gao C, et al. Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension. Bioconjugate Chemistry. PMID 30912649 DOI: 10.1021/Acs.Bioconjchem.9B00170 |
0.46 |
|
| 2019 |
White JB, Fleming R, Masterson L, Ruddle BT, Zhong H, Fazenbaker C, Strout P, Rosenthal K, Reed M, Muniz-Medina V, Howard P, Dixit R, Wu H, Hinrichs MJ, Gao C, et al. Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer. Mabs. 1-16. PMID 30835621 DOI: 10.1080/19420862.2019.1578611 |
0.537 |
|
| 2019 |
Dimasi N, Fleming R, Wu H, Gao C. Molecular engineering strategies and methods for the expression and purification of IgG1-based bispecific bivalent antibodies. Methods. 154: 77-86. PMID 30102989 DOI: 10.1016/J.Ymeth.2018.08.004 |
0.447 |
|
| 2018 |
Kumar A, Kinneer K, Masterson L, Ezeadi E, Howard P, Wu H, Gao C, Dimasi N. Characterization and in vitro data of antibody drug conjugates (ADCs) derived from heterotrifunctional linker designed for the site-specific preparation of dual ADCs. Data in Brief. 21: 2208-2220. PMID 30533469 DOI: 10.1016/J.Dib.2018.11.005 |
0.488 |
|
| 2018 |
Kumar A, Kinneer K, Masterson L, Ezeadi E, Howard P, Wu H, Gao C, Dimasi N. Synthesis of a heterotrifunctional linker for the site-specific preparation of antibody-drug conjugates with two distinct warheads. Bioorganic & Medicinal Chemistry Letters. PMID 30389292 DOI: 10.1016/J.Bmcl.2018.10.043 |
0.405 |
|
| 2018 |
St Amant AH, Lemen D, Florinas S, Mao S, Fazenbaker C, Zhong H, Wu H, Gao C, Christie RJ, Read de Alaniz J. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers. Bioconjugate Chemistry. PMID 29932647 DOI: 10.1021/Acs.Bioconjchem.8B00320 |
0.411 |
|
| 2018 |
Oganesyan V, Peng L, Bee JS, Li J, Perry SR, Comer F, Xu L, Cook K, Senthil K, Clarke L, Rosenthal K, Gao C, Damschroder M, Wu H, Dall'Acqua WF. Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody. The Journal of Biological Chemistry. PMID 29669810 DOI: 10.1074/Jbc.M117.818013 |
0.336 |
|
| 2017 |
Christie RJ, Tiberghien AC, Du Q, Bezabeh B, Fleming R, Shannon A, Mao S, Breen S, Zhang J, Zhong H, Harper J, Wu H, Howard PW, Gao C. Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation. Antibodies (Basel, Switzerland). 6. PMID 31548535 DOI: 10.3390/Antib6040020 |
0.443 |
|
| 2017 |
Portnoff AD, Gao C, Borrok MJ, Gao X, Gao C, Rainey GJ. An antidote approach to reduce risk and broaden utility of antibody based therapeutics. The Journal of Biological Chemistry. PMID 28258216 DOI: 10.1074/Jbc.M117.775528 |
0.482 |
|
| 2017 |
Dimasi N, Fleming R, Zhong H, Bezabeh B, Kinneer K, Christie RJ, Fazenbaker C, Wu H, Gao C. Efficient preparation of site-specific antibody drug conjugates using cysteine-insertion. Molecular Pharmaceutics. PMID 28245132 DOI: 10.1021/Acs.Molpharmaceut.6B00995 |
0.579 |
|
| 2017 |
Kasturirangan S, Rainey GJ, Xu L, Wang X, Portnoff A, Chen T, Fazenbaker C, Zhong H, Bee J, Zeng Z, Jenne C, Wu H, Gao C. Targeted FcγR mediated clearance by a biparatopic bispecific antibody. The Journal of Biological Chemistry. PMID 28100773 DOI: 10.1074/Jbc.M116.770628 |
0.477 |
|
| 2017 |
Dimasi N, Fleming R, Sachsenmeier KF, Bezabeh B, Hay C, Wu J, Sult E, Rajan S, Zhuang L, Cariuk P, Buchanan A, Bowen MA, Wu H, Gao C. Guiding bispecific monovalent antibody formation through proteolysis of IgG1 single-chain. Mabs. 0. PMID 28055299 DOI: 10.1080/19420862.2016.1277301 |
0.533 |
|
| 2017 |
Mao S, Garcia A, Chen T, Chaerkady R, Marreno A, Zhong H, Toader D, Dimasi N, Kennedy M, Howard P, Gao C, Wu H, Herbst R, Tice D, Harper J. Abstract 2064: Tumor cells treated with a PBD-based antibody-drug conjugate targeting 5T4 develop acquired resistance due to 5T4 down-regulation and response to alternate therapeutics Cancer Research. 77: 2064-2064. DOI: 10.1158/1538-7445.Am2017-2064 |
0.397 |
|
| 2017 |
Chen S, Florinas S, Teitgen A, Xu Z, Gao C, Wu H, Kataoka K, Cabral H, Christie RJ. Controlled Fab installation onto polymeric micelle nanoparticles for tuned bioactivity Science and Technology of Advanced Materials. 18: 666-680. DOI: 10.1080/14686996.2017.1370361 |
0.361 |
|
| 2017 |
Kumar A, White J, Christie RJ, Dimasi N, Gao C. Antibody-Drug Conjugates Annual Reports in Medicinal Chemistry. DOI: 10.1016/Bs.Armc.2017.08.002 |
0.489 |
|
| 2016 |
Bezabeh B, Fleming R, Fazenbaker C, Zhong H, Coffman K, Yu XQ, Leow CC, Gibson N, Wilson S, Stover CK, Wu H, Gao C, Dimasi N. Insertion of scFv into the hinge domain of full-length IgG1 monoclonal antibody results in tetravalent bispecific molecule with robust properties. Mabs. 0. PMID 27981887 DOI: 10.1080/19420862.2016.1270492 |
0.513 |
|
| 2016 |
Thompson P, Ezeadi E, Hutchinson I, Fleming R, Bezabeh B, Lin J, Mao S, Chen C, Masterson L, Zhong H, Toader D, Howard P, Wu H, Gao C, Dimasi N. Straightforward Glycoengineering Approach to Site-Specific Antibody-Pyrrolobenzodiazepine Conjugates. Acs Medicinal Chemistry Letters. 7: 1005-1008. PMID 27882199 DOI: 10.1021/Acsmedchemlett.6B00278 |
0.566 |
|
| 2016 |
Peng L, Cook K, Xu L, Cheng L, Damschroder M, Gao C, Wu H, Dall'Acqua WF. Molecular basis for the mechanism of action of an anti-TACE antibody. Mabs. 0. PMID 27610476 DOI: 10.1080/19420862.2016.1226716 |
0.453 |
|
| 2016 |
Thompson P, Fleming R, Bezabeh B, Huang F, Mao S, Chen C, Harper J, Zhong H, Gao X, Yu XQ, Hinrichs MJ, Reed M, Kamal A, Strout P, Cho S, ... ... Gao C, et al. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27327768 DOI: 10.1016/J.Jconrel.2016.06.025 |
0.55 |
|
| 2016 |
Florinas S, Liu M, Fleming R, Van Vlerken-Ysla L, Ayriss J, Gilbreth R, Dimasi N, Gao C, Wu H, Xu ZQ, Chen S, Dirisala A, Kataoka K, Cabral H, Christie RJ. A Nanoparticle Platform to Evaluate Bioconjugation and Receptor-Mediated Cell Uptake using Crosslinked Polyion Complex Micelles Bearing Antibody Fragments. Biomacromolecules. PMID 27007881 DOI: 10.1021/Acs.Biomac.6B00239 |
0.435 |
|
| 2016 |
Li JY, Perry SR, Muniz-Medina V, Wang X, Wetzel LK, Rebelatto MC, Hinrichs MJ, Bezabeh BZ, Fleming RL, Dimasi N, Feng H, Toader D, Yuan AQ, Xu L, Lin J, ... Gao C, et al. A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy. Cancer Cell. 29: 117-29. PMID 26766593 DOI: 10.1016/J.Ccell.2015.12.008 |
0.431 |
|
| 2016 |
Li J, Perry S, Muniz-Medina V, Wetzel L, Rebelatto M, Bezabeh B, Fleming R, Dimasi N, Gao C, Wu H, Jenkins D, Osbourn J, Coats S. Abstract PD5-08: A biparatopic HER2-targeting antibody-drug conjugate demonstrates potent antitumor activity in primary tumor models that are refractory to or ineligible for HER2-targeted therapies Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-Pd5-08 |
0.39 |
|
| 2016 |
Li J, Toader D, Perry SR, Muniz-Medina V, Wetzel L, Rebelatto MC, Hinrichs MJM, Fleming R, Bezabeh B, Thompson P, Dimasi N, Lam B, Yu X, Gao C, Dixit R, et al. Abstract 2970: MEDI4276, a HER2-targeting antibody tubulysin conjugate, displays potent invitroandin vivoactivity in preclinical studies Cancer Research. 76: 2970-2970. DOI: 10.1158/1538-7445.Am2016-2970 |
0.529 |
|
| 2015 |
Xiao X, Chen Y, Mugabe S, Gao C, Tkaczyk C, Mazor Y, Pavlik P, Wu H, Dall'Acqua W, Chowdhury PS. A Novel Dual Expression Platform for High Throughput Functional Screening of Phage Libraries in Product like Format. Plos One. 10: e0140691. PMID 26468955 DOI: 10.1371/Journal.Pone.0140691 |
0.371 |
|
| 2015 |
Hirose H, Tamai H, Gao C, Imamura A, Ando H, Ishida H, Feizi T, Kiso M. Total syntheses of disulphated glycosphingolipid SB1a and the related monosulphated SM1a. Organic & Biomolecular Chemistry. PMID 26399908 DOI: 10.1039/C5Ob01744K |
0.301 |
|
| 2015 |
James Christie R, Fleming R, Bezabeh B, Woods R, Mao S, Harper J, Joseph A, Wang Q, Xu ZQ, Wu H, Gao C, Dimasi N. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26387744 DOI: 10.1016/J.Jconrel.2015.09.032 |
0.355 |
|
| 2015 |
Thompson P, Bezabeh B, Fleming R, Pruitt M, Mao S, Strout P, Chen C, Cho S, Zhong H, Wu H, Gao C, Dimasi N. Hydrolytically Stable Site-Specific Conjugation at the N-Terminus of an Engineered Antibody. Bioconjugate Chemistry. PMID 26340339 DOI: 10.1021/Acs.Bioconjchem.5B00355 |
0.527 |
|
| 2015 |
Dimasi N, Fleming R, Hay C, Woods R, Xu L, Wu H, Gao C. Development of a trispecific antibody designed to simultaneously and efficiently target three different antigens on tumor cells. Molecular Pharmaceutics. PMID 26176328 DOI: 10.1021/Acs.Molpharmaceut.5B00268 |
0.544 |
|
| 2015 |
Rios-Doria J, Sabol D, Chesebrough J, Stewart D, Xu L, Tammali R, Cheng L, Du Q, Schifferli K, Rothstein R, Leow CC, Heidbrink-Thompson J, Jin X, Gao C, Friedman J, et al. A Monoclonal Antibody to ADAM17 Inhibits Tumor Growth by Inhibiting EGFR and Non-EGFR-Mediated Pathways. Molecular Cancer Therapeutics. 14: 1637-49. PMID 25948294 DOI: 10.1158/1535-7163.Mct-14-1040 |
0.371 |
|
| 2015 |
Mao S, Fleming R, Bezabeh B, Dimasi N, Toader D, Cailleau T, Howard P, Gao C, Hollingsworth B, Kamal A, Harper J. Abstract 3601: Antibody-drug conjugates (ADCs) with tubulysin and PBD warheads, maintain potent in vitro cytotoxicity against multidrug-resistant tumor cells expressing P-glycoprotein (P-gp) Cancer Research. 75: 3601-3601. DOI: 10.1158/1538-7445.Am2015-3601 |
0.331 |
|
| 2015 |
Toader D, Harper J, Lloyd C, Marwood R, Bannister D, Mao S, Chen C(, Zhong H(, Bedian V, Wang F, Gingipalli L, Vasbinder M, Thompson P, Fleming R, Bezabeh B, ... ... Gao C, et al. Abstract B170: Discovery of tubulysin payloads for antibody drug conjugates with potentin vitroactivityandin vivoefficacy in solid tumor models Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B170 |
0.505 |
|
| 2015 |
Cai X, Globisch D, Thompson P, Lin J, Toader D, Dimasi N, Gao C, Janda KD. Corrigendum to "A chemoenzymatic approach toward the preparation of site-specific antibody-drug conjugates" [Tetrahedron Lett. 56 (2015) 3172-3175] Tetrahedron Letters. DOI: 10.1016/J.Tetlet.2015.06.088 |
0.722 |
|
| 2014 |
DiGiandomenico A, Keller AE, Gao C, Rainey GJ, Warrener P, Camara MM, Bonnell J, Fleming R, Bezabeh B, Dimasi N, Sellman BR, Hilliard J, Guenther CM, Datta V, Zhao W, ... Gao C, et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Science Translational Medicine. 6: 262ra155. PMID 25391481 DOI: 10.1126/Scitranslmed.3009655 |
0.469 |
|
| 2014 |
Oganesyan V, Damschroder MM, Cook KE, Li Q, Gao C, Wu H, Dall'Acqua WF. Structural insights into neonatal Fc receptor-based recycling mechanisms. The Journal of Biological Chemistry. 289: 7812-24. PMID 24469444 DOI: 10.1074/Jbc.M113.537563 |
0.324 |
|
| 2014 |
Hollingsworth RE, Kamal A, Howard PW, Hartley JA, Tice D, Gao C, Dimasi N, Zhong H, Harper J, Xiao Z, Toader D, Martin C, Wu H, Greenberg N, Jallal B. Abstract 2659: The MedImmune ADC platform: Building highly potent and specific cancer drugs Cancer Research. 74: 2659-2659. DOI: 10.1158/1538-7445.Am2014-2659 |
0.448 |
|
| 2013 |
Devanaboyina SC, Lynch SM, Ober RJ, Ram S, Kim D, Puig-Canto A, Breen S, Kasturirangan S, Fowler S, Peng L, Zhong H, Jermutus L, Wu H, Webster C, Ward ES, ... Gao C, et al. The effect of pH dependence of antibody-antigen interactions on subcellular trafficking dynamics. Mabs. 5: 851-9. PMID 24492341 DOI: 10.4161/Mabs.26389 |
0.484 |
|
| 2013 |
Xu L, Jin X, Rainey GJ, Wu H, Gao C. A mammalian expression system for high throughput antibody screening. Journal of Immunological Methods. 395: 45-53. PMID 23831609 DOI: 10.1016/J.Jim.2013.06.009 |
0.491 |
|
| 2013 |
Sachsenmeier KF, Dimasi N, Huang Q, Sult E, Bezabeh B, Fleming R, Hay C, Zhong H, Breen S, Gao C, Agoram B, Jermutus L, Hollingsworth R. Abstract 4635: The avidity hypothesis: comparing bispecific and monospecific antibodies in preclinical oncology models. Cancer Research. 73: 4635-4635. DOI: 10.1158/1538-7445.Am2013-4635 |
0.532 |
|
| 2009 |
Dimasi N, Gao C, Fleming R, Woods RM, Yao XT, Shirinian L, Kiener PA, Wu H. The design and characterization of oligospecific antibodies for simultaneous targeting of multiple disease mediators. Journal of Molecular Biology. 393: 672-92. PMID 19699208 DOI: 10.1016/J.Jmb.2009.08.032 |
0.546 |
|
| 2009 |
Bruckheimer EM, Fazenbaker CA, Gallagher S, Mulgrew K, Fuhrmann S, Coffman KT, Walsh W, Ready S, Cook K, Damschroder M, Kinch M, Kiener PA, Woods R, Gao C, Dall'Acqua W, et al. Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors. Neoplasia (New York, N.Y.). 11: 509-17, 2 p followin. PMID 19484140 DOI: 10.1593/Neo.81578 |
0.498 |
|
| 2008 |
Jackson D, Gooya J, Mao S, Kinneer K, Xu L, Camara M, Fazenbaker C, Fleming R, Swamynathan S, Meyer D, Senter PD, Gao C, Wu H, Kinch M, Coats S, et al. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo. Cancer Research. 68: 9367-74. PMID 19010911 DOI: 10.1158/0008-5472.Can-08-1933 |
0.506 |
|
| 2008 |
Oganesyan V, Gao C, Shirinian L, Wu H, Dall'Acqua WF. Structural characterization of a human Fc fragment engineered for lack of effector functions. Acta Crystallographica. Section D, Biological Crystallography. 64: 700-4. PMID 18560159 DOI: 10.1107/S0907444908007877 |
0.373 |
|
| 2006 |
Mulgrew K, Kinneer K, Yao XT, Ward BK, Damschroder MM, Walsh B, Mao SY, Gao C, Kiener PA, Coats S, Kinch MS, Tice DA. Direct targeting of alphavbeta3 integrin on tumor cells with a monoclonal antibody, Abegrin. Molecular Cancer Therapeutics. 5: 3122-9. PMID 17172415 DOI: 10.1158/1535-7163.Mct-06-0356 |
0.395 |
|
| 2005 |
Moss JA, Lillo A, Kim YS, Gao C, Ditzel H, Janda KD. A dimerization "switch" in the internalization mechanism of a cell-penetrating peptide. Journal of the American Chemical Society. 127: 538-9. PMID 15643874 DOI: 10.1021/Ja0443171 |
0.617 |
|
| 2004 |
Felding-Habermann B, Lerner RA, Lillo A, Zhuang S, Weber MR, Arrues S, Gao C, Mao S, Saven A, Janda KD. Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis. Proceedings of the National Academy of Sciences of the United States of America. 101: 17210-5. PMID 15563590 DOI: 10.1073/Pnas.0407869101 |
0.642 |
|
| 2004 |
Lillo AM, Sun C, Gao C, Ditzel H, Parrish J, Gauss CM, Moss J, Felding-Habermann B, Wirsching P, Boger DL, Janda KD. A human single-chain antibody specific for integrin alpha3beta1 capable of cell internalization and delivery of antitumor agents. Chemistry & Biology. 11: 897-906. PMID 15271348 DOI: 10.1016/J.Chembiol.2004.04.018 |
0.724 |
|
| 2003 |
Gao C, Mao S, Ronca F, Zhuang S, Quaranta V, Wirsching P, Janda KD. De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods. Journal of Immunological Methods. 274: 185-97. PMID 12609544 DOI: 10.1016/S0022-1759(02)00522-7 |
0.538 |
|
| 2002 |
Gao C, Mao S, Ditzel HJ, Farnaes L, Wirsching P, Lerner RA, Janda KD. A cell-penetrating peptide from a novel pVII-pIX phage-displayed random peptide library. Bioorganic & Medicinal Chemistry. 10: 4057-65. PMID 12413859 DOI: 10.1016/S0968-0896(02)00340-1 |
0.468 |
|
| 2002 |
Lee KJ, Mao S, Sun C, Gao C, Blixt O, Arrues S, Hom LG, Kaufmann GF, Hoffman TZ, Coyle AR, Paulson J, Felding-Habermann B, Janda KD. Phage-display selection of a human single-chain fv antibody highly specific for melanoma and breast cancer cells using a chemoenzymatically synthesized G(M3)-carbohydrate antigen. Journal of the American Chemical Society. 124: 12439-46. PMID 12381184 DOI: 10.1021/Ja020737J |
0.539 |
|
| 2002 |
Gao C, Mao S, Kaufmann G, Wirsching P, Lerner RA, Janda KD. A method for the generation of combinatorial antibody libraries using pIX phage display. Proceedings of the National Academy of Sciences of the United States of America. 99: 12612-6. PMID 12239343 DOI: 10.1073/Pnas.192467999 |
0.73 |
|
| 2001 |
Kozlov IA, Mao S, Xu Y, Huang X, Lee L, Sears PS, Gao C, Coyle AR, Janda KD, Wong CH. Synthesis of solid-supported mirror-image sugars: a novel method for selecting receptors for cellular-surface carbohydrates. Chembiochem : a European Journal of Chemical Biology. 2: 741-6. PMID 11948856 DOI: 10.1002/1439-7633(20011001)2:10<741::Aid-Cbic741>3.0.Co;2-B |
0.492 |
|
| 1999 |
Mao S, Gao C, Lo CH, Wirsching P, Wong CH, Janda KD. Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proceedings of the National Academy of Sciences of the United States of America. 96: 6953-8. PMID 10359820 DOI: 10.1073/Pnas.96.12.6953 |
0.654 |
|
| 1999 |
Gao C, Mao S, Lo CH, Wirsching P, Lerner RA, Janda KD. Making artificial antibodies: a format for phage display of combinatorial heterodimeric arrays. Proceedings of the National Academy of Sciences of the United States of America. 96: 6025-30. PMID 10339535 DOI: 10.1073/Pnas.96.11.6025 |
0.577 |
|
| 1999 |
Gao C, Brümmer O, Mao S, Janda KD. Selection of Human Metalloantibodies from a Combinatorial Phage Single-Chain Antibody Library Journal of the American Chemical Society. 121: 6517-6518. DOI: 10.1021/Ja990966E |
0.606 |
|
| 1999 |
Brümmer O, Gao C, Mao S, Weiner DP, Janda KD. Design, synthesis and characterization of panning agents for the selection of metalloantibodies Letters in Peptide Science. 6: 295-302. DOI: 10.1007/Bf02443425 |
0.499 |
|
| 1998 |
Heine A, Stura EA, Yli-Kauhaluoma JT, Gao C, Deng Q, Beno BR, Houk KN, Janda KD, Wilson IA. An antibody exo Diels-Alderase inhibitor complex at 1.95 angstrom resolution. Science (New York, N.Y.). 279: 1934-40. PMID 9506943 DOI: 10.1126/Science.279.5358.1934 |
0.666 |
|
| 1998 |
Gao C, Lavey BJ, Lo CL, Datta A, Wentworth P, Janda KD. Direct Selection for Catalysis from Combinatorial Antibody Libraries Using a Boronic Acid Probe: Primary Amide Bond Hydrolysis Journal of the American Chemical Society. 120: 2211-2217. DOI: 10.1021/Ja9720220 |
0.556 |
|
| 1997 |
Gao C, Lin CH, Lo CH, Mao S, Wirsching P, Lerner RA, Janda KD. Making chemistry selectable by linking it to infectivity. Proceedings of the National Academy of Sciences of the United States of America. 94: 11777-82. PMID 9342313 DOI: 10.1073/Pnas.94.22.11777 |
0.558 |
|
| 1996 |
Lo CHL, Gao C, Mao S, Matsui K, Lerner RA, Janda KD. Chain shuffling: Investigations into the specificity and selectivity of antibody catalysis Israel Journal of Chemistry. 36: 195-198. DOI: 10.1002/Ijch.199600026 |
0.632 |
|
| Show low-probability matches. |